Impact of Weight Loss Drugs on Sexual Health
A recent study has revealed that a popular weight loss medication may influence sexual health as well. According to a 2025 review from the National Institutes of Health, GLP-1 (glucagon-like peptide-1) drugs were found to boost testosterone levels, enhance hormone balance, and improve erectile function in men who are overweight or obese.
Other reviews corroborate these findings, noting similar positive effects on erectile dysfunction. But there’s a catch. A separate study published in the Sage Journal in June highlighted that for women, these drugs could potentially decrease sexual drive due to their hormonal effects.
A nationally representative study from Indiana University’s Kinsey Institute reported mixed results among GLP-1 users: around 52% indicated that the drug had both positive and negative influences on their sex lives. Specifically, 18% noted an increase in desire, while 16% experienced a decrease. Additionally, 16% said their sexual function improved, whereas 14% did not observe any change.
Varying Experiences
Dr. Peter Balazs, who specializes in hormone and weight loss treatment in New York and New Jersey, expressed that pinpointing whether the sexual function improvements stem directly from the medication or better self-esteem post-weight loss is challenging. He emphasizes that these outcomes heavily depend on individual patient characteristics.
For example, while individuals with severe obesity often see significant hormonal enhancements, those with chronic diabetic neuropathy may face irreversible nerve damage, limiting the drug’s effectiveness. Balazs also cautions that if sexual issues are mainly stemming from emotional or relationship factors, merely relying on medication might not resolve the underlying problems.
Interestingly, younger men—particularly those under 30—were more likely to report declines in libido. Balazs suggests this could be tied to the drug’s influence on the central nervous system, rather than pre-existing health conditions.
Understanding the Mechanism
GLP-1 appears to play a role in enhancing sexual function by improving endothelial performance, which supports better blood flow—crucial for cardiovascular and erectile health. For women, enhanced blood circulation in the pelvic area is also beneficial.
Moreover, notable weight loss can hinder the conversion of testosterone to estrogen, ultimately helping to restore testosterone levels. Balazs adds that this improvement leads to better libido, increased energy, and enhanced sexual function. Interestingly, he notes that GLP-1 might reduce brain inflammation and improve peripheral nerve function, which are vital for physical sensations.
Obesity often acts as a barrier to intimacy, and shedding some pounds can significantly improve mobility and comfort. Balazs points out that the psychological effects of obesity and diabetes, such as anxiety and depression—often contributors to sexual dysfunction—can be alleviated through weight loss.
However, Balazs also mentions that diminished sexual function while using GLP-1 medications could be linked to how the brain’s reward systems operate. He states that the modulation of this pathway, which governs pleasure from both eating and sex, might lead to decreased sexual desire in some users. He also notes that side effects like nausea and psychological adjustments following rapid weight loss may further diminish enthusiasm for sexual activity.
